Health
The Oxford vaccine dilemma – wait for a better jab, or let more people have protection? – Telegraph.co.uk
Regulator seems ready to approve a vaccine with lower efficacy rates. Will it be right giving some people lower chances of being protected?
Drug companies Sanofi and GSK also announced a delay in their Covid-19 vaccine programme on Friday, after trials showed an ‘insufficient response’ in the over-50s.
Some researchers believe the Oxford jab may actually perform better than the 62 per cent efficacy rate suggests. Nobody in the vaccine arm became seriously ill or needed hospital treatment.
Mark Woolhouse, Professor of Infectious Disease Epidemiology at the University of Edinburgh, said: I dont think we should get too hung up on the…
-
Noosa News24 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General18 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General23 hours agoOlder Aussies back increased superannuation tax
-
Noosa News21 hours agoTips to improve engagement – Proctor